Table 1 characteristics of two primary cancer.

From: Prognosis of male lung cancer patients with urinary cancer: a study from a national population-based analysis

	LCBC				BCLC				LCPC				PCLC
	Overall	sTPC	mTPC1	mTPC2	Overall	sTPC	mTPC1	mTPC2	Overall	sTPC	mTPC1	mTPC2	Overall	sTPC	mTPC1	mTPC2
No
	343	118	143	82	1539	182	651	706	1181	374	538	269	7426	685	2969	3772
Race
NHW	314	113	124	77	1363	166	570	627	867	261	400	206	5422	484	2154	2784
NHB	15	4	11	0	72	12	30	30	212	79	87	46	1252	128	528	596
NHA	6	1	2	3	59	3	26	30	52	18	26	8	372	37	145	190
Hispanic	8	0	6	2	43	1	25	17	48	16	23	9	358	36	132	190
Others	0	0	0	0	2	0	0	2	2	0	2	0	22	0	10	12
Sex
	Male	Male	Male	Male	Male	Male	Male	Male	Male	Male	Male	Male	Male	Male	Male	Male
First diagnosis of year
> 2005	145	64	66	15	510	108	311	91	449	159	159	131	1653	154	518	981
1995–2005	119	32	49	38	596	47	222	327	366	89	176	101	3559	221	1205	2133
< 1995	79	22	28	29	433	27	118	288	366	126	203	37	2214	310	1246	658
Age of first diagnosis
Median	70	71	71	67	69	71	71	65	67	71	67	62	68	70	70	67
IQR	64–76	66–77	64–78	60–72	62–75	67–78	65–77	58–72	61–73	65–76	62–73	56–67	63–73	65–75	65–75	62–72
First insurance status
No	1	1	0	0	3	1	1	1	6	1	4	1	17	2	9	6
Yes	130	55	62	13	412	92	259	61	306	109	171	26	1587	242	944	401
Unknown	212	62	81	69	1124	89	391	644	869	264	363	242	5822	441	2016	3365
First marital status
Single	82	31	36	15	333	45	166	122	306	138	117	51	1568	159	675	734
Married	254	86	102	66	1147	132	459	556	849	227	408	214	5146	446	1959	2741
Unknown	7	1	5	1	59	5	26	28	26	9	13	4	712	80	335	297
First site
	17	17	17	17	3	3	3	3	17	17	17	17	16	16	16	16
First histology
	8140	8140	8140	8140	8130	8130	8130	8130	8140	8140	8140	8140	8140	8140	8140	8140
First cancer stage
Localized	124	18	59	47	1411	148	601	662	403	56	243	104	6448	502	2632	3314
Regional	94	32	45	17	99	26	39	34	278	62	147	69
Distant	70	47	21	2	2	1	0	1	204	138	51	15	180	69	69	42
Unstaged	55	21	18	16	27	7	11	9	296	118	97	81	798	114	268	416
First surgery
No	140	74	61	5	51	7	24	20	403	254	131	18	4367	503	1947	1917
Yes	199	41	81	77	1485	175	624	686	762	108	404	250	2966	159	987	1820
Unknown	4	3	1	0	3		3	0	16	12	3	1	93	23	35	35
First radiotherapy
No	2	2	0	0					3	2		1	59	4	30	25
Yes	130	56	58	16	24	6	12	6	325	138	135	52	3053	177	1300	1576
Unknown	211	60	85	66	1515	176	639	700	853	234	403	216	4314	504	1639	2171
Interval time (month)
Median	21	1	25	100.5	55	2	31	117	21	1	26	104	62	2	31	108
IQR	3–58	0–4	15–40	75–162	22–108	1–4	19–46	83–156	3–56	0–3	15–40	80–141	26–109	1–4	19–45	81–147
Secondary insurance
No	1	1	0	0	5	0	3	2	3	2	1		34	4	16	14
Yes	174	53	72	49	852	93	348	411	401	89	200	112	4363	279	1438	2646
Unknown	168	64	71	33	682	89	300	293	777	283	337	157	3029	402	1515	1112
Secondary marital status
Single	88	32	36	20	422	44	184	194	297	128	111	58	2059	169	807	1083
Married	230	80	95	55	1061	132	447	482	754	211	363	180	5088	488	2051	2549
Unknown	25	6	12	7	56	6	20	30	130	35	64	31	279	28	111	140
Secondary diagnosis of year
> 2005	199	64	80	55	944	109	385	450	343	157	138	48	669	153	340	176
1995–2005	91	33	39	19	398	46	180	172	314	90	143	81	1961	217	1005	739
< 1995	53	21	24	8	197	27	86	84	524	127	257	140	4796	315	1624	2857
Age of secondary diagnosis
Median	73	71	73	76	75	72	73	76	70	71	69	72	75	70	73	77
IQR	67–80	66–77	66–80	70–82	69–80	67–78	68–80	70–82	65–76	65–76	65–75	67–77	69–80	65–75	68–78	72–82
Secondary site
	3	3	3	3	17	17	17	17	16	16	16	16	17	17	17	17
Secondary histology
	8130	8130	8130	8130	8140	8140	8140	8140	8140	8140	8140	8140	8140	8140	8140	8140
Secondary cancer stage
Localized	283	98	120	65	288	54	112	122	824	204	389	231	1270	125	497	648
Regional	21	11	6	4	277	37	130	110	-	-	-	-	1400	165	575	660
Distant	3	2	0	1	753	66	319	368	83	39	30	14	3855	286	1584	1985
Unstaged	36	7	17	12	221	25	90	106	274	131	119	24	901	109	313	479
Secondary surgery
No	23	10	10	3	1131	118	467	546	846	279	390	177	5586	432	2206	2948
Yes	320	108	133	79	389	62	177	150	304	78	137	89	1771	241	736	794
Unknown	0	0	0	0	19	2	7	10	31	17	11	3	69	12	27	30
Secondary radiotherapy
No	0	0	0	0	15	1	5	9	5	2	3	0	75	2	35	38
Yes	12	7	2	3	568	55	245	268	355	59	190	106	2709	245	1155	1309
Unknown	331	111	141	79	956	126	401	429	821	313	345	163	4642	438	1779	2425
Survival time since lung primary (month)
Mean	53	11	52	160.5	7	11	8	6	66	9	70	167	7	11	8	7
IQR	20–125	44–705	33–95	107–217	44–611	4–33	44–612	44–608	18–132	3–21.5	39–108	124–218	44–613	3–32	44–614	44–610
Major cause of cancer-related death
	LUAC	LUAC	LUAC	LUAC	LUAC	LUAC	LUAC	LUAC	LUAC	LUAC	LUAC	LUAC	LUAC	LUAC	LUAC	LUAC
Major cause of noncancer-related death
	HD	HD	HD	HD	HD	HD	HD	HD	HD	HD	HD	HD	HD	HD	HD	HD

LCBC lung cancer with subsequent bladder cancer; BCLC bladder cancer with subsequent lung cancer; LCPC lung cancer with subsequent prostate cancer; PCLC prostate cancer with subsequent lung cancer; NHW non-hispanic white; NHB non-hispanic black; NHA non-hispanic asian or pacific islander; histology 8140 adenocarcinoma; histology 8130 papillary transitional cell carcinoma; site 3 bladder; site 16 prostate; site 17 lung and bronchus; LUAC lung adenocarcinoma; HD heart disease.

Back to article page

Table 1 characteristics of two primary cancer.

Search

Quick links